SHANGHAI, June 5, 2025 /PRNewswire/ -- The 2025 ASCO Annual Meeting successfully concluded in Chicago on June 3 (local time). Hengrui Pharma delivered a strong international presence, featuring 15 innovative drugs and 72 research outcomes. These included 4 oral presentations, 5 rapid oral...
Read More Details
Finally We wish PressBee provided you with enough information of ( Hengrui Pharma Showcases Global Impact at the 2025 ASCO: 72 Study Results Highlight Chinese Cancer Innovation )
Also on site :
- Amazon Has ‘Awesome’ $30 Arch Support Flip Flops on Sale for $12, and Reviewers Are ‘Stunned’ How Comfortable They Are
- Today’s NYT ‘Strands’ Hints, Spangram and Answers for Saturday, June 7
- Pop Icon Looks Unrecognizable After Ditching '80s Glam in Makeup-Free Selfie